Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiperinuclear activity in lung carcinoma patients.

Literature DB >> 6334550

Antiperinuclear activity in lung carcinoma patients.

P Youinou, C Zabbe, C Eveillaud, J D Dewitte, J F Kerbourc'h, C Ferec, J Clavier.

Abstract

Antiperinuclear factor (APF) might be a specific serum rheumatoid factor directed towards keratohyaline granules. It was found to be present in 40 of 79 (50.6%) patients with primary and in 21 of 36 (58.3%) patients with metastatic lung cancer, compared with 12 of 95 (12.6%) sex- and age-matched normal controls. Additionally, APF frequency and titer correlated well with tumor dissemination, even though no relationship could be shown with histopathological type.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1984 PMID： 6334550 DOI： 10.1007/bf00205738

Source DB: PubMed Journal: Cancer Immunol Immunother ISSN： 0340-7004 Impact factor: 6.968

14 in total

1. Antibodies and anti-antibodies in human malignancy: an expression of deranged immune regulation.

Authors: M G Lewis; D Hartman; L M Jerry
Journal: Ann N Y Acad Sci Date: 1976 Impact factor: 5.691

2. A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

Authors: R L NIENHUIS; E MANDEMA
Journal: Ann Rheum Dis Date: 1964-07 Impact factor: 19.103

Review 3. The suppressor-cell network in cancer (second of two parts).

Authors: S Broder; T A Waldmann
Journal: N Engl J Med Date: 1978-12-14 Impact factor: 91.245

4. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis].

Authors: P Youinou; P Le Goff; P Miossec; M P Moineau; C Ferec
Journal: Z Rheumatol Date: 1983 Jan-Feb Impact factor: 1.372

1. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.

Authors: R M Hoet; A M Boerbooms; M Arends; D J Ruiter; W J van Venrooij
Journal: Ann Rheum Dis Date: 1991-09 Impact factor: 19.103

1 in total

Antiperinuclear activity in lung carcinoma patients.

1. Antibodies and anti-antibodies in human malignancy: an expression of deranged immune regulation.

2. A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

Review 3. The suppressor-cell network in cancer (second of two parts).

4. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis].

5. Immune complexes and human neoplasia.

6. Rheumatoid factors in the sera of patient with gastrointestinal carcinoma.

7. The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.

8. Rheumatoid factor: correlation with recurrence in transitional cell carcinoma of the bladder.

9. Rheumatoid factor and tumor-host interaction.

Review 10. Rheumatoid factor: its nature, specificity, and production in rheumatoid arthritis.

1. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.